| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |